GeneDx Holdings Corp. ($WGS) is capturing the attention of investors and industry experts alike with a forecasted return that defies conventional expectations. Our proprietary quantitative model projects an extraordinary +3,500% return for $WGS in the current year, positioning it as the top-ranked stock among 168 equities we track. This forecast reflects more than just numbers; it signals a profound shift in precision genomics and molecular diagnostics, driven by GeneDx’s lea